LD-2 disclosure · 3rd Quarter - Amendment
GLENMARK PHARMACEUTICALS, INC., USA
Client
- Description
- Leading,integrated, research-driven, global pharmaceutical manufacturing company.
- Location
- New Jersey · United States of America
Registrant
- Description
- Federal lobbying and consulting services
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesMedicare/Medicaid
Issues related to Medicaid CPI Penalty.
LobbyistsDAVID PAUL PELUSO · MJ KENNY · LISA KOUNTOUPES
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
General education about the generic pharmaceutical industry.
Lobbyistsms MARY R "RANDI" REID · DAVID PAUL PELUSO · MJ KENNY · LISA KOUNTOUPES
Covered position (MJ KENNY): Deputy Floor Director, Floor Assistant - Office of the Senate Democratic Whip; Legislative Aide, Legislative Correspondent - Senator Richard J. Durbin (D-IL)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Issues related to the abuses of the patent system, extensions of drug exclusivity, pay-for-delay, and the inter partes review (IPR) process, including H. R. 1499, the Protecting Consumer Access to Generic Drugs Ace of 2019, and H. R. 938, the BLOCKING Act of 2019.
Lobbyistsms MARY R "RANDI" REID · DAVID PAUL PELUSO · MJ KENNY · ROSE SULLIVAN (LISTED IN ERROR) · LISA KOUNTOUPES